The speed of blood pressure fluctuations in patients with chronic obstructive pulmonary disease

Heart Lung and Circulation

Volumn 23, Issue 3, 2014, Pages 280-286

  Van Gestel, Arnoldus J R ^a,b   Clarenbach, Christian F ^a   Stöwhas, Anne Christin ^a   Rossi, Valentina A ^a   Sievi, Noriane A ^a   Camen, Giovanni ^a   Kohler, Malcolm ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Blood pressure variability; Cardiovascular risk; Changes; Chronic obstructive pulmonary disease; Forced expiratory volume in 1s; Speed of blood pressure

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE VARIABILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CHANGES; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; FORCED EXPIRATORY VOLUME IN 1S; SPEED OF BLOOD PRESSURE;

ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84896738201     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.08.010     Document Type: Article

References (50)

1. Clarenbach C.F., Senn O., Sievi N.A., Camen G., van Gestel A.J.R., Rossi V.A., et al. Determinants of endothelial function in patients with COPD. Eur Respir J 2013, 10.1183/09031936.00144612.
2. Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008, 32:962-969.
3. Sin D.D., Anthonisen N.R., Soriano J.B., Agusti A.G. Mortality in COPD: role of comorbidities. Eur Respir J 2006, 28(6):1245-1257.
4. Sidney S., Sorel M., Quesenberry C.P. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005, 128:2068-2075.
5. Anthonisen N.R., Connett J.E., Enright P.L., Manfreda J. Lung Health Study Research Group: hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002, 166(3):333-339.
6. Sin D.D., Man S.F.P. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 2005, 83:8-13.
7. Feary J.R., Rodrigues L.C., Smith C.J., Hubbard R.B., Gibson J.E. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010, 65(11):956-962.
8. Curkendall S.M., DeLuise C., Jones J.K. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006, 16:63-70.
9. Hole D.J., Watt G.C., Davey-Smith G. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley Prospective Population Study. BMJ 1996, 313:711-715.
10. Truelsen T., Prescott E., Lange P., Schnohr P., Boysen G. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol 2001, 30:145-151.
11. Sorlie P.D., Kannel W.B., O'Connor G. Mortality associated with respiratory function and symptoms in advanced age. The Framingham Study. Am Rev Respir Dis 1989, 140:379-384.
12. Mancia G., Parati G., Pomidossi G., Casadei R., Di Rienzo M., Zanchetti A. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension 1986, 8:147-153.
13. Mancia G., Ferrari A., Gregorini L. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983, 53:96-104.
14. Rim S.-J. Blood pressure variation and cardiovascular risks. Korean Circ J 2008, 38:131-134.
15. Patakas D., Louridas G., Kakavelas E. Reduced baroreceptor sensitivity in patients with chronic obstructive pulmonary disease. Thorax 1982, 37:292-295.
16. Heindl S., Lehnert M., Criée C.P. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001, 164:597-601.
17. Parati G., Faini A., Valentini M. Blood pressure variability: its measurement and significance in hypertension. Curr Hypertens Rep 2006, 8(3):199-204.
18. Grove J.S., Reed D.M., Yano K., Hwang L.J. Variability in systolic blood pressure-a risk factor for coronary heart disease?. Am J Epidemiol 1997, 145:771-776.
19. Rothwell P.M., Howard S.C., Dolan E. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010, 375(9718):895-905.
20. Rothwell P.M., Howard S.C., Dolan E. on behalf of the ASCOT-BPLA and MRC Trial Investigators: effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010, 9:469-480.
21. MacKenzie E.T., Strandgaard S., Graham D.I., Jones J.V., Harper A.M., Farrar J.K. Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res 1976, 39:33-41.
22. Tatasciore A., Renda G., Zimarino M. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007, 50(2):325-332.
23. Chappell D.C., Varner S.E., Nerem R.M., Medford R.M., Alexander R.W. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res 1998, 82:532-539.
24. De Keulenaer G.W., Chapell D.C., Ishikaza N., Nerem R.M., Alexander R.W., Griendling K.K. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 1998, 82:1094-1101.
25. van Gestel A.J.R., Camen G., Clarenbach C.F., Sievi N., Rossi V.A., Kohler M. Quantifying the speed of fluctuations in systolic blood pressure. Hypertens Res 2013, 10.1038/hr.2013.62.
26. Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Chronic Respir Dis 2010, 7(3):131-133.
27. Kurki T., Smith N.T., Head N., Dec-Silver H., Quinn A. Noninvasive continuous blood pressure measurement from the finger: optimal measurement conditions and factors affecting reliability. J Clin Monit 1987, 3:6-13.
28. Smith N.T., Wesseling K.W., De Wit B. Evaluation of two prototype devices producing noninvasive pulsatile calibrated blood pressure from a finger. J Clin Monit 1985, 1:17-29.
29. Imholz B.P., Wieling W., Montfrans G.A., Wesseling K.A. Fifteen years experience with finger arterial pressure monitoring. Cerebrovasc Res 1998, 38:605-616.
30. Omboni S., Parati G., Castiglioni P. Estimation of blood pressure variability from 24-hour ambulatory finger blood pressure. Hypertension 1998, 32:52-58.
31. Schutte A.E., Huisman H.W., van Rooyen H.W., Malan J.M., Schutte N.T.R. Validation of the Finometer device for measurement of blood pressure in black women. J Human Hypertens 2004, 18:79-84.
32. Guelen I. Finometer, finger pressure measurements with the possibility to reconstruct brachial pressure. Blood Press Monit 2003, 8:27-30.
33. Akselrod S., Gordon D., Madwed J.B., Snidman N.C., Shannon D.C., Cohen R.J. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol Heart Circ Physiol 1985, 249:867-875.
34. Claude J. The enigma of Mayer waves: facts and models. Cardiovasc Res 2006, 70:12-21.
35. Miller M.R., Hankinson J., Brusasco V. Series ATS/ERS task force: standardisation of spirometry. Eur Respir J 2005, 26:319-338.
36. Crapo R.O., Morris A.H., Gardner R.M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981, 123:659-664.
37. Bilo G., Parati G. Rate of blood pressure changes assessed by 24h ambulatory blood pressure monitoring: another meaningful index of blood pressure variability?. J Hypertens 2011, 29:1054-1058.
38. Sander D., Kukla C., Klingelhofer J., Winbeck K., Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000, 102(13):1536-1541.
39. Van Montfrans G.A. High prognostic significance of blood pressure variability in consecutive checks. Ned Tijdsschr Geneesk 2010, 154:2670.
40. Vestbo J., Hurd S.S., Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what?. Clin Respir J 2012, 6(4):208-214.
41. Hansen T.W., Thijs L., Li Y., Boggia J., Kikuya M., Björklund-Bodegard K., et al. Prognostic value of reading-to-reading blood pressure variability over 24hours in 8938 subjects from 11 populations. Hypertension 2010, 55:1049-1057.
42. Mancia G., Parati G., Castiglioni P., Tordi R., Tortorici E., Glavina F., et al. Daily life blood pressure changes are steeper in hypertensive than in normotensive subjects. Hypertension 2003, 42:277-282.
43. Zakopoulos N.A., Tsivgoulis G., Barlas G., Papamichael C., Spengos K., Manios E., et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005, 45(4):505-512.
44. Manios E., Stamatelopoulos K., Tsivgoulis G. Time rate of blood pressure variation: a new factor associated with coronary atherosclerosis. J Hypertens 2011, 29(6):1109-1114.
45. Laitinen T., Hartikainen J., Niskanen L., Geelen G., Länsimies E. Sympathovagal balance is major determinant of short-term blood pressure variability in healthy subjects. Am J Physiol Heart Circ Physiol 1999, 276:1245-1252.
46. Bigger J.T, Kleiger R.E., Fleiss J.L. Components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol 1988, 61:208-215.
47. Bilmann G.E., Schwartz P.J., Stone H.L. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 1982, 66:874-880.
48. van Gestel A.J.R., Steier J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD). J Thorac Dis 2010, 2:215-222.
49. van Gestel A.J.R., Kohler M., Clarenbach C.F. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD). Discov Med 2012, 14(79):359-368.
50. Salpeter S.R., Ormiston T.M., Salpeter E.E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004, 125:2309-2321.